Prognostic or predictive? It's time to get back to definitions!

Journal of Clinical Oncology

Volumn 29, Issue 35, 2011, Pages 4718-

  Italiano, Antoine ^a  

^a INSTITUT BERGONIÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; STAT5 PROTEIN;

BREAST CANCER; CANCER HORMONE THERAPY; CANCER SURVIVAL; HUMAN; LETTER; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TREATMENT OUTCOME;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; HUMANS; NEOPLASM PROTEINS; NUCLEAR PROTEINS; STAT5 TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEINS;

EID: 83255162591     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.38.3729     Document Type: Letter

References (2)

1. Peck AR, Witkiewicz AK, Liu C, et al.: Loss of nuclear localized and tyrosine phosphorylated Stat5 in breast cancer predicts poor clinical outcome and increased risk of antiestrogen therapy failure. J Clin Oncol 29:2448-2458, 2011
2. Mandrekar SJ, Sargent DJ: Predictive biomarker validation in practice: Lessons from real trials. Clin Trials 7:567-573, 2010